Sri Biotech Laboratories

Hyderabad, India Founded: 1994 • Age: 32 yrs Acquired By Valagro
Crop improvement research and nutrient manufacturing are conducted.

About Sri Biotech Laboratories

Sri Biotech Laboratories is a Healthcare company based in Hyderabad (India) founded in 1994, and was acquired by Valagro in March 2015. Crop improvement research and nutrient manufacturing are conducted. It operates in the Healthcare and Agriculture sectors. Sri Biotech Laboratories has raised $9 million across 2 funding rounds from investors including Valagro, Rabo Equity Advisors and Department of Biotechnology. The company has 59 employees. Its Indian entity Sri Bioaesthetics Private Limited reported revenue of β‚Ή9.29 Cr. Its focus areas include Life Sciences, Genomics, Applied Genomics and Agrigenomics. Its competitors include Nuziveedu Seeds, IPL Biologicals and Kan biosys; 3 of its 3 listed competitors have raised funding.

Company details

Sri Biotech Laboratories is focussed on doing research for improving the crop yield by improving the crop nutrition and better crop protection. The research is based on both organic and inorganic nutrients and fertilizers as well as pesticides and other crop protection products. Apart from RD it also manufactures and sells crop nutrients and crop protection chemicals. It has a 100 acres Research farm located at Nandigama. It has 2 manufacturing facilities at Hyderabad and Guntur and claims to be catering to 10M farmers in 13 states in India. In Nov 2015, Rabo Equity which had invested 9M, exited selling its stake to Italy based Valagro SpA, which now owns a controlling stake in the company.

  • Headquarters Hyderabad, India
  • Employees 59
  • Stage Acquired
  • Sectors
    Healthcare
    Agriculture
  • Website sribio.com
  • Acquired by Valagro (Mar 2015)
  • Legal Name Sri Bioaesthetics Private Limited
  • Date of Incorporation 21 Jul, 2016
  • Jurisdiction Hyderabad, Telangana, India
Key Metrics
  • Annual Revenue
    ₹9.29 Cr

    FY 2024 · +15% YoY

  • Net Loss
    -₹5.8 Lakh

    FY 2024 · -1% margin

  • EBITDA
    ₹52.2 Lakh

    FY 2024 · 6% margin

  • Total Equity Funding
    $9M (USD)

    in 2 rounds

  • Investors
    Valagro

    & 2 more

  • Employee Count
    59
  • Acquired by
    Valagro

    (Mar 2015)

Funding Insights of Sri Biotech Laboratories

Sri Biotech Laboratories has successfully raised a total of $9M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $9M
  • Total Rounds 2
  • First Round $9M

    (Mar 2009)

  • Investors Count 2

All 2 funding rounds of Sri Biotech Laboratories with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2011Grant––
Mar 2009$9MSeries A––
Valuation history

3 investors in total: 3 institutional.

Investors in Sri Biotech Laboratories

Sri Biotech Laboratories has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include Valagro, Rabo Equity Advisors and Department of Biotechnology.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Biotechnology research, guidelines, and funding by the Government of India.
1986dbtindia.gov.inDelhi, India
Manages diversified investment funds and portfolios for clients.
1972raboequity.comDelhi, India
Biological products are supplied for agriculture, gardening, and turf management.
1980valagro.comAtessa, Italy
Premium access

Investor details for Sri Biotech Laboratories

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Sri Bioaesthetics Private Limited (Sri Biotech Laboratories)

Sri Bioaesthetics Private Limited is the primary company behind Sri Biotech Laboratories. The board of Sri Bioaesthetics Private Limited currently have 6 directors; the longest-serving is Rama Kondamadugula Koti Reddy, appointed in 2016. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rama Kondamadugula Koti Reddy
DIN 00259576
Managing Director21 Jul 201610 yrs 3 moSri Bioaesthetics Private Limited
Kondamadugula Anuradha
DIN 02128286
Director21 Jul 201610 yrs 3 moSri Bioaesthetics Private Limited
Venkat Rayudu Goluguri
DIN 07682552
Director16 Dec 20169 yrs 10 moSri Bioaesthetics Private Limited
Sri Varshitha Kondamadugula
DIN 08046268
Whole-time director08 Jan 20188 yrs 10 moSri Bioaesthetics Private Limited
Vinuthna Reddy Kondamadugula
DIN 02964755
Director29 Nov 20187 yrs 11 moSri Bioaesthetics Private Limited
Chavva Narapuram Nikhil Reddy
DIN 09164931
Additional Director23 Nov 20241 yr 11 moSri Bioaesthetics Private Limited

Financials of Sri Biotech Laboratories

Figures of Sri Bioaesthetics Private Limited, the primary company behind Sri Biotech Laboratories, for FY 2024. Revenue was ₹9.29 Cr (+15% year on year). Net loss was -₹5.8 Lakh (-1% margin). EBITDA was ₹52.2 Lakh (6% margin). Revenue has grown at a compounded annual rate of +19% over three years and +136% over five years.

  • ₹9.29 CrRevenue · FY 2024 · +15% YoY
  • -₹5.8 LakhNet loss · -1% margin
  • ₹52.2 LakhEBITDA · 6% margin
  • ₹9.51 CrPaid-up capital
  • 59Employees (provident fund records)
  • +19%Revenue CAGR, 3 years
  • +136%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Sri Bioaesthetics Private Limited are on its company page.

Premium access

Detailed financial statements for Sri Biotech Laboratories

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Sri Biotech Laboratories

4 dated milestones of Sri Biotech Laboratories across 21 years, from founding to its latest funding, stage changes and deals.

  1. Founded Sri Biotech Laboratories is founded.
  2. Funding First funding round of $9.0M.
  3. Funding Latest funding round, Grant,.
  4. Exit Acquired by Valagro.

Competitors of Sri Biotech Laboratories

Sri Biotech Laboratories has 3 listed competitors in our database, 3 of them funded. They include Nuziveedu Seeds, IPL Biologicals and Kan biosys.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nuziveeduseeds.com1973Hyderabad, India$104.71M1,258
Improved crop varieties and hybrids are developed and marketed.
iplbiologicals.com1994Gurugram, India$4.66M901
Plant nutrition and protection products are manufactured and supplied.
kanbiosys.com2005Pune, India$1.02M256
Microbes-based biological solutions for crop diversification are provided.
Premium access

Detailed competitors of Sri Biotech Laboratories

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sri Biotech Laboratories

Premium access

Complete news archive for Sri Biotech Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sri Biotech Laboratories

Sri Biotech Laboratories was founded in 1994 and raised its 1st funding round 15 years after it was founded.

Sri Biotech Laboratories is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

Sri Biotech Laboratories is a funded company, having raised a total of $9M across 2 funding rounds to date. The company's 1st funding round was a Series A of $9M, raised on Mar 2009.

Sri Biotech Laboratories has 59 employees.

The primary company behind Sri Biotech Laboratories, Sri Bioaesthetics Private Limited, reported revenue of β‚Ή9.29 Cr for FY 2024, up 15% year on year.

Sri Biotech Laboratories is focussed on doing research for improving the crop yield by improving the crop nutrition and better crop protection. The research is based on both organic and inorganic nutrients and fertilizers as well as pesticides and other crop protection products. Apart from RD it also manufactures and sells crop nutrients and crop protection chemicals. It has a 100 acres Research farm located at Nandigama. It has 2 manufacturing facilities at Hyderabad and Guntur and claims to be catering to 10M farmers in 13 states in India. In Nov 2015, Rabo Equity which had invested 9M, exited selling its stake to Italy based Valagro SpA, which now owns a controlling stake in the company.

Sri Biotech Laboratories's top competitors include Nuziveedu Seeds, IPL Biologicals and Kan biosys.

Sri Biotech Laboratories has 3 investors. Key investors include Valagro, Rabo Equity Advisors, and Department of Biotechnology.

Sri Biotech Laboratories operates through Sri Bioaesthetics Private Limited.

Yes. Sri Biotech Laboratories was acquired by Valagro in March 2015.

The legal entities of Sri Biotech Laboratories currently have 6 directors, including Rama Kondamadugula Koti Reddy, Sri Varshitha Kondamadugula, Chavva Narapuram Nikhil Reddy and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available